Article
Downregulated the expression of DNMT3B by suppressing PI3K/Akt signaling pathway and enhances the chemosensitivity of glioblastoma to temozolomide.
2023-10-03
Abstract excerpt
<title>Abstract</title> <p>Purpose Glioblastoma is the most common malignant brain tumors and has the poorest prognosis. And a poor prognosis is attributed to chemoresistance to temozolomide (TMZ), the first-line drug for treating glioblastoma. This study aimed to investigate how to enhance the chemosensitivity of glioblastoma to temozolomide. Methods Human glioblastoma cell line U251 was used to established te...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- beb9e15a-b2e6-519f-86e3-659af8c307b4
- DOI
- 10.21203/rs.3.rs-3358904/v1
